Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Bhumika Madhav (Navi Mumbai, India), T.K. Jayalakshmi, Aparna Iyer, Bhumika Madhav. Diagnostic yield of AFB smear, culture, LiPA, GeneXpert: A clinician’s perspective. Eur Respir J 2015; 46: Suppl. 59, 1531

Member's Comments

No comment yet.

Related content which might interest you: Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Xpert MTB/RIF testing of pooled induced sputum Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 To determine diagnostic accuracy of gene xpert and sputum Ziehl-Neelsen staining taking sputum culture as gold standard Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Estimation of the role of the test GeneXpert MTB-RIF in the diagnosis of pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Clinical utility of the Xpert MTB/RIF test in induced sputum Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Cartridge based nucleic acid amplification technique (CBNATT) for diagnosis of rifampicin resistance from sputum smear in revised national tuberculosis control of India (RNTCP) – Implications of preliminary data Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Interpretation of indeterminate RIF-susceptibility results obtained by rapid molecular diagnostics test Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Gene-Xpert for rapid detection of MDR-TB in re-treatment cases;a comparison with standard culture and DST Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Detection of TB by smear microscopy and GeneXpert MTB/RIF assay in non expectorating pulmonary TB suspects and pleural TB in high prevalent low income setting Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 The application of the the Xpert MTB/RIF in the Moscow Scientific and Clinical Antituberculosis Center Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Online method for diagnosing sputum smears negative TB cases in a developing country Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013 Study of diagnostic sensitivity for mycobacterium tuberculosis(MTB) by smear, culture and Xpert MTB/RIF assay in pleural specimens obtained by medical thoracoscopy. Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018 Tuberculosis diagnosis in rural Namibia using gene Xpert MTB/RIF testing Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Factors that predict for positive GeneXpert MTB/RIF on bronchoalveolar lavage samples in children with suspected tuberculosis Source: International Congress 2014 – Paediatric bronchology Year: 2014 Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis Source: Eur Respir J 2012; 40: 442-447 Year: 2012 Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Source: Eur Respir J 2012; 40: 161-168 Year: 2012